Virtus ETF Advisers’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,680
| Closed | -$341K | – | 295 |
|
|
2024
Q4 | $341K | Buy |
10,680
+2,942
| +38% | +$93.9K | 0.14% | 215 |
|
|
2024
Q3 | $223K | Hold |
7,738
| – | – | 0.1% | 245 |
|
|
2024
Q2 | $297K | Buy |
7,738
+436
| +6% | +$16.7K | 0.15% | 230 |
|
|
2024
Q1 | $429K | Buy |
7,302
+1,051
| +17% | +$61.8K | 0.23% | 189 |
|
|
2023
Q4 | $374K | Buy |
6,251
+2,950
| +89% | +$177K | 0.24% | 176 |
|
|
2023
Q3 | $126K | Sell |
3,301
-429
| -12% | -$16.3K | 0.08% | 319 |
|
|
2023
Q2 | $340K | Sell |
3,730
-2,117
| -36% | -$193K | 0.2% | 167 |
|
|
2023
Q1 | $386K | Buy |
5,847
+104
| +2% | +$6.86K | 0.21% | 149 |
|
|
2022
Q4 | $297K | Sell |
5,743
-313
| -5% | -$16.2K | 0.16% | 270 |
|
|
2022
Q3 | $414K | Buy |
6,056
+86
| +1% | +$5.88K | 0.17% | 225 |
|
|
2022
Q2 | $270K | Sell |
5,970
-2,755
| -32% | -$125K | 0.1% | 279 |
|
|
2022
Q1 | $443K | Hold |
8,725
| – | – | 0.2% | 138 |
|
|
2021
Q4 | $413K | Buy |
8,725
+1,673
| +24% | +$79.2K | 0.16% | 137 |
|
|
2021
Q3 | $232K | Sell |
7,052
-641
| -8% | -$21.1K | 0.1% | 229 |
|
|
2021
Q2 | $486K | Buy |
7,693
+1,932
| +34% | +$122K | 0.2% | 156 |
|
|
2021
Q1 | $247K | Buy |
5,761
+93
| +2% | +$3.99K | 0.1% | 291 |
|
|
2020
Q4 | $324K | Sell |
5,668
-4,279
| -43% | -$245K | 0.13% | 189 |
|
|
2020
Q3 | $300K | Sell |
9,947
-1,352
| -12% | -$40.8K | 0.16% | 223 |
|
|
2020
Q2 | $369K | Sell |
11,299
-1,697
| -13% | -$55.4K | 0.17% | 239 |
|
|
2020
Q1 | $348K | Sell |
12,996
-1,892
| -13% | -$50.7K | 0.14% | 209 |
|
|
2019
Q4 | $456K | Buy |
14,888
+2,953
| +25% | +$90.4K | 0.07% | 215 |
|
|
2019
Q3 | $288K | Sell |
11,935
-665
| -5% | -$16K | 0.06% | 201 |
|
|
2019
Q2 | $319K | Sell |
12,600
-1,738
| -12% | -$44K | 0.07% | 199 |
|
|
2019
Q1 | $280K | Sell |
14,338
-1,568
| -10% | -$30.6K | 0.6% | 64 |
|
|
2018
Q4 | $210K | Sell |
15,906
-4,989
| -24% | -$65.9K | 0.04% | 176 |
|
|
2018
Q3 | $372K | Sell |
20,895
-15,328
| -42% | -$273K | 0.04% | 170 |
|
|
2018
Q2 | $797K | Buy |
+36,223
| New | +$797K | 0.7% | 29 |
|